These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8303305)

  • 41. Regulatory balance between the immune response of tumor antigen-specific T-cell receptor gene-transduced CD8 T cells and the suppressive effects of tolerogenic dendritic cells.
    Fujii S; Nishimura MI; Lotze MT
    Cancer Sci; 2005 Dec; 96(12):897-902. PubMed ID: 16367910
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon-alpha and interleukin-12 gene therapy of cancer: interferon-alpha induces tumor-specific immune responses while interleukin-12 stimulates non-specific killing.
    Eguchi J; Hiroishi K; Ishii S; Mitamura K
    Cancer Immunol Immunother; 2003 Jun; 52(6):378-86. PubMed ID: 12739068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth.
    Campbell I; Moyana T; Carlsen S; Zheng C; Xiang J
    Cancer Gene Ther; 2000 Jan; 7(1):37-44. PubMed ID: 10678354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In situ cytokine gene transfection using vaccinia virus vectors.
    Lattime EC; Lee SS; Eisenlohr LC; Mastrangelo MJ
    Semin Oncol; 1996 Feb; 23(1):88-100. PubMed ID: 8607035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
    Baxevanis CN; Perez SA; Papamichail M
    Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.
    Knutson KL; Disis ML
    Cancer Immunol Immunother; 2005 Aug; 54(8):721-8. PubMed ID: 16010587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines.
    Jaffee EM; Pardoll DM
    Methods; 1997 Jun; 12(2):143-53. PubMed ID: 9184378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting innate immune pathways in cancer immunotherapy: state of the art.
    Mastellos DC
    J BUON; 2009 Sep; 14 Suppl 1():S123-30. PubMed ID: 19785054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Thymus hormones in the immunotherapy of malignant neoplasms (a review of the literature)].
    Nikol'skiĭ IS
    Vrach Delo; 1988 Aug; (8):77-82. PubMed ID: 3061171
    [No Abstract]   [Full Text] [Related]  

  • 50. Cytokine gene transfer for the treatment of cancer.
    Bruyns C; Gérard C; Velu T
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S17-20. PubMed ID: 8177710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. p53 as a target for anti-cancer immunotherapy.
    Chen HL; Carbone DP
    Mol Med Today; 1997 Apr; 3(4):160-7. PubMed ID: 9134529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alteration of signal transduction in T cells from cancer patients.
    Ochoa AC; Longo DL
    Important Adv Oncol; 1995; ():43-54. PubMed ID: 7672813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune control of neoplasia by adoptive transfer of macrophages: potentiality for antigen presentation and gene transfer.
    Bartholeyns J; Lopez M
    Anticancer Res; 1994; 14(6B):2673-6. PubMed ID: 7872699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immunological analysis of chemotherapeutic effects for the effective immunochemotherapy against cancer].
    Yamada Y
    Hokkaido Igaku Zasshi; 1984 Nov; 59(6):721-7. PubMed ID: 6397415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The biology of cancer gene therapy.
    Whartenby KA; Abboud CN; Marrogi AJ; Ramesh R; Freeman SM
    Lab Invest; 1995 Feb; 72(2):131-45. PubMed ID: 7853848
    [No Abstract]   [Full Text] [Related]  

  • 56. Tumor-cell-targeted cytokine gene transfer in experimental models for cancer therapy.
    Hock H; Dorsch M; Richter G; Kunzendorf U; Krüger-Krasagakes S; Blankenstein T; Qin Z; Diamantstein T
    Nat Immun; 1994; 13(2-3):85-92. PubMed ID: 8173239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer immunotherapy with autologous and allogeneic vaccines: a practical overview.
    Shinitzky M; Skornick Y
    Prog Clin Biol Res; 1990; 348():95-125. PubMed ID: 2201036
    [No Abstract]   [Full Text] [Related]  

  • 58. [Immunity and immunosuppression in tumor growth].
    Govallo VI
    Vopr Onkol; 1987; 33(4):91-9. PubMed ID: 3296437
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunotherapeutic strategies for neoplasia.
    Talmadge JE
    Dev Biol Stand; 1992; 77():17-28. PubMed ID: 1426659
    [No Abstract]   [Full Text] [Related]  

  • 60. [Interleukin-2 and cancer immunotherapy].
    Ogarkov VI; Dobkin AI; Ryzhova EV; Okulov VB; Kiselev OI
    Vopr Onkol; 1989; 35(2):141-50. PubMed ID: 2648678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.